|
|
| (21 intermediate revisions by 4 users not shown) |
| Line 101: |
Line 101: |
| | </div> | | </div> |
| | </div> | | </div> |
| − | <div class="row">
| |
| − | <div class="col-md-6 left">
| |
| − | <h3 class="title">Bronze </h2>
| |
| − | <div class="space30"></div>
| |
| − | <p class="space20">We’ve registered our team, had a great summer and are looking forward to the iGEM Jamboree! We’ve got a poster and a presentation ready to present there and we’ve completed our iGEM 2015 Judging form.
| |
| − | </p>
| |
| − |
| |
| − | <p class="space20">We’ve made a wiki including a <a href="https://2015.igem.org/Team:NRP-UEA-Norwich/Description" style = "color: #002bb8;">Description page</a>.</p>
| |
| − |
| |
| − | <p class="space20">We’ve put plenty of new parts in the Registry of Standard Biological Parts - there is a list on our <a href="https://2015.igem.org/Team:NRP-UEA-Norwich/Parts" style = "color: #002bb8;">Parts page</a>.</p>
| |
| − | <p class="space20">We’ve listed all the people who have helped and trained us on our <a href="https://2015.igem.org/Team:NRP-UEA-Norwich/Attributions" style = "color: #002bb8;">Attributions page</a>.</p>
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | </div>
| |
| − | <div class="col-md-5 col-md-offset-1 col-sm-offset-1 space30 text-center">
| |
| − | <div class="space30"></div>
| |
| − | <div class="success-work science">
| |
| − |
| |
| − | <img src="https://static.igem.org/mediawiki/2015/7/71/NRP-UEA-Norwich-bronze-medal.png" href="https://static.igem.org/mediawiki/2015/7/71/NRP-UEA-Norwich-bronze-medal.png" alt="..." class="img-responsive mautomargin fancybox" style="cursor: pointer; width: 250px; height: 345px;">
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − | </div>
| |
| − |
| |
| − | </div>
| |
| − |
| |
| − | </div>
| |
| | | | |
| | <div class="row"> | | <div class="row"> |
| | <div class="col-md-6 left"> | | <div class="col-md-6 left"> |
| − | <h3 class="title">Silver</h2> | + | <h3 class="title">We're back!</h3> |
| | <div class="space30"></div> | | <div class="space30"></div> |
| − | <p class="space20"> We’ve experimentally validated several BioBrick Parts. You can find data in the registry and on our <a href="https://2015.igem.org/ Team:NRP-UEA-Norwich /Results" style = "color: #002bb8;">Results page</a>. </p> | + | <p class="space20"> The NRP-UEA iGEM team attended the 2015 iGEM Giant Jamboree at the Hynes Convention Center, Boston, MA. |
| − | <p><a href="http://parts.igem.org/Part:BBa_K1618029" style = "color: #002bb8;">BBa_K1618029</a></p>
| + | We entered the Food and Nutrition Track and gave a <a href="https://2015.igem.org/ files/poster/NRP-UEA-Norwich. pdf" style = "color: #002bb8;"> poster</a> and a <a href="https://2015.igem.org/ files/ presentation/NRP-UEA-Norwich. pdf" style = "color: #002bb8;"> presentation</a>. We achieved a Gold Medal and were also nominated for the Best Food and Nutrition Project Award and for the Best Education and Public Engagement, Undergrad Category.</p> |
| − | <p><a href="http://parts.igem.org/Part:BBa_K1618030" style = "color: #002bb8;">BBa_K1618030</a></p>
| + | |
| − | <p><a href ="http://parts.igem.org/Part:BBa_K1618031" style = "color: #002bb8;">BBa_K1618031</a></p> | + | |
| − | <p><a href="http://parts.igem.org/Part:BBa_K1618032" style = "color: #002bb8;">BBa_K1618032</a></p>
| + | |
| − | <p><a href="http://parts.igem.org/Part:BBa_K1618037" style = "color: #002bb8;">BBa_K1618037</a></p>
| + | |
| − | <p><a href="http://parts.igem.org/Part:BBa_K1618028" style = "color: #002bb8;">BBa_K1618028</a></p>
| + | |
| − | | + | |
| − | </div>
| + | |
| − | <div class="col-md-5 col-md-offset-1 col-sm-offset-1 space30 text-center">
| + | |
| − | <div class="space30"></div>
| + | |
| − | <div class="success-work project">
| + | |
| − |
| + | |
| − | <img src="https://static.igem.org/mediawiki/2015/b/b7/NRP-UEA-Norwich-silver-medal.png" href="https://static.igem.org/mediawiki/2015/b/b7/NRP-UEA-Norwich-silver-medal.png" alt="..." class="img-responsive mautomargin fancybox" style="cursor: pointer; width: 250px; height: 345px;">
| + | |
| − | | + | |
| − |
| + | |
| − | </div>
| + | |
| − |
| + | |
| − | </div>
| + | |
| − | <div class="col-md-12 left">
| + | |
| − | <p class="space20">There are significant ethical considerations with the production of bioengineered food supplements. By talking to Cancer charities, people who run trials to test the effects of diet on health, and the public we found out that while the genetic engineering of food is still controversial in Europe, opinions may differ when the reasons for engineering are for the prevention of cancer. You can read all about these studies on our <a href="https://2015.igem.org/Team:NRP-UEA-Norwich/Practices" style = "color: #002bb8;">Practices page</a>.</p>
| + | |
| − | </div>
| + | |
| − | </div>
| + | |
| − | | + | |
| − | <div class="row">
| + | |
| − | <div class="col-md-6 left">
| + | |
| − | <h3 class="title">Gold</h3>
| + | |
| − | <div class="space30"></div>
| + | |
| − | <h4 class="title2">Advanced Practices</h4>
| + | |
| − | <p class="space20">We have expanded on our Integrated Practices because we are making foods and food supplements about which we would like to make a health-claim. We investigated how we would collect data to show if our products reduce cancer incidence in humans. We consulted experts in the Medical and Nutrition Faculty who have expertise in designing intervention/feeding studies.</p>
| + | |
| − | | + | |
| − | <p class="space10">Having learned about what can be tested and measured and what de-regulation is needed for testing, we designed a theoretical feeding trial that they evaluated for us. Should we develop a product that performs in animal trials we could now progress to deregulation and funding for human trials. There are many projects aiming for healthier foods but few that consider how to prove this experimentally. </p>
| + | |
| − | | + | |
| − | <p>We believe this study is novel and worth highlighting to the iGEM community.
| + | |
| − | </p> | + | |
| | | | |
| | | | |
| Line 186: |
Line 122: |
| | | | |
| | | | |
| − | </div>
| |
| | | | |
| | </div> | | </div> |
| | | | |
| − | <div class="col-md-12 left">
| + | |
| − | <p class="space20">There are significant ethical considerations with the production of bioengineered food supplements. By talking to Cancer charities, people who run trials to test the effects of diet on health, and the public we found out that while the genetic engineering of food is still controversial in Europe, opinions may differ when the reasons for engineering are for the prevention of cancer. You can read all about these studies on our <a href="https://2015.igem.org/Team:NRP-UEA-Norwich/Practices" style = "color: #002bb8;">Practices page</a>.</p>
| + | |
| | + | |
| | + | |
| | + | |
| | </div> | | </div> |
| | </div> | | </div> |
| Line 222: |
Line 160: |
| | <li><img src="https://static.igem.org/mediawiki/2015/9/9c/NRP-UEA-Norwich-Ibcarb_logo.png" width="200" height="100" class="img-grey mautomargin"></a></li> | | <li><img src="https://static.igem.org/mediawiki/2015/9/9c/NRP-UEA-Norwich-Ibcarb_logo.png" width="200" height="100" class="img-grey mautomargin"></a></li> |
| | <li><img src="https://static.igem.org/mediawiki/2015/8/8b/NRP-UEA-Norwich-TSL-logo.png" width="200" height="100" class="img-grey mautomargin"></a></li> | | <li><img src="https://static.igem.org/mediawiki/2015/8/8b/NRP-UEA-Norwich-TSL-logo.png" width="200" height="100" class="img-grey mautomargin"></a></li> |
| − | <li><img src="https://static.igem.org/mediawiki/2015/f/f0/NRP-UEA-Norwich-Biochemsociety.png" width="225" height="100" class="img-grey mautomargin"></a></li> | + | <li><img src="https://static.igem.org/mediawiki/2015/7/7d/NRP-UEA-Norwich-SEB-Logo.png" width="225" height="100" class="img-grey mautomargin"></a></li> |
| | <li><img src="https://static.igem.org/mediawiki/2015/d/d3/NRP-UEA-Norwich-JIC.png" width="200" height="100" class="img-grey mautomargin" width="200" height="100"></a></li> | | <li><img src="https://static.igem.org/mediawiki/2015/d/d3/NRP-UEA-Norwich-JIC.png" width="200" height="100" class="img-grey mautomargin" width="200" height="100"></a></li> |
| | <li><img src="https://static.igem.org/mediawiki/2015/c/c5/NRP-UEA-Norwich-Bbsrc.png" width="200" height="100" class="img-grey mautomargin"></a></li> | | <li><img src="https://static.igem.org/mediawiki/2015/c/c5/NRP-UEA-Norwich-Bbsrc.png" width="200" height="100" class="img-grey mautomargin"></a></li> |
| Line 229: |
Line 167: |
| | <li><img src="https://static.igem.org/mediawiki/2015/e/e3/NRP-UEA-Norwich-Wellcome_Trust_logo.png" width="250" height="100" class="img-grey mautomargin"></a></li> | | <li><img src="https://static.igem.org/mediawiki/2015/e/e3/NRP-UEA-Norwich-Wellcome_Trust_logo.png" width="250" height="100" class="img-grey mautomargin"></a></li> |
| | <li><img src="https://static.igem.org/mediawiki/2015/7/74/NRP-UEA-Norwich-IBBA_logo.png" width="125" height="125" class="img-grey mautomargin"></a></li> | | <li><img src="https://static.igem.org/mediawiki/2015/7/74/NRP-UEA-Norwich-IBBA_logo.png" width="125" height="125" class="img-grey mautomargin"></a></li> |
| | + | <li><img src="https://static.igem.org/mediawiki/2015/d/d0/NRP-UEA-Norwich-SfAM-Logo.png" width="220" height="100" class="img-grey mautomargin" width="200" height="100"></a></li> |
| | | | |
| | | | |
